Average deal sizes are also at their highest levels for many years, according to Allen & Overy’s latest M&A Index.
For now, the recovery is looking resilient and optimism is high, fuelled by low interest rates and large cash reserves on corporate balance sheets, although the equity markets are currently undergoing some unhelpful volatility, says the firm. According to the research, deal values for 2014 are, thus far, up 51 per cent on the same period in 2013. More significantly, the value of cross-border transactions is higher than at any time since 2007, with US companies leading the charge, followed by growing activity from Chinese, UK, German and Canadian strategic investors. “CEO confidence is certainly back,” says Andrew Ballheimer, Allen & Overy’s global co-head of corporate. “It is apparent in the size of transactions, with 70 deals worth more than $5bn compared to 52 this time last year. “But, more importantly, it is evident in the scope of and ambition of transactions. There have been a number of highly strategic deals which have been significant enough to transform companies and in some cases, entire sectors. This consolidation, which has defined the landscapes of several sectors, has driven companies to reassess their strategies. CEOs are acting while market conditions are favourable, rather than risking being left on the sidelines.” Traditionally, the third quarter is quieter for M&A activity, due to the summer months, but transactions have continued at a healthy pace and the deal pipeline is strong enough to suggest the recovery will continue through the winter and into 2015. TMT continues to be the leader by deal value, followed by life sciences, with the number of deals so far in 2014 for the former, exceeding the whole of 2013.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.